THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 122 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $311,741 | -4.3% | 36,123 | +14.7% | 0.00% | – |
| Q2 2023 | $325,839 | +43.2% | 31,482 | +48.5% | 0.00% | – |
| Q1 2023 | $227,519 | +59.7% | 21,204 | +67.0% | 0.00% | – |
| Q4 2022 | $142,472 | -85.3% | 12,698 | -55.1% | 0.00% | -100.0% |
| Q3 2017 | $968,000 | -13.5% | 28,279 | +0.7% | 0.00% | 0.0% |
| Q2 2017 | $1,119,000 | -1.1% | 28,081 | -8.7% | 0.00% | 0.0% |
| Q1 2017 | $1,132,000 | – | 30,753 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 10,898,879 | $264,297,000 | 23.51% |
| Foundation Asset Management, LP | 399,537 | $9,689,000 | 3.59% |
| Cormorant Asset Management, LP | 1,300,000 | $31,525,000 | 2.35% |
| Baupost Group | 9,309,168 | $225,747,000 | 2.18% |
| Old West Investment Management, LLC | 109,320 | $2,651,000 | 1.53% |
| SENZAR ASSET MANAGEMENT, LLC | 187,856 | $4,555,000 | 1.44% |
| Chescapmanager LLC | 350,631 | $8,503,000 | 1.27% |
| Virtus ETF Advisers LLC | 32,989 | $800,000 | 0.69% |
| Rock Springs Capital Management LP | 652,600 | $15,826,000 | 0.68% |
| NJ State Employees Deferred Compensation Plan | 34,142 | $828,000 | 0.15% |